Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07315685

Understanding and Treating Severe and Resistant Pathological Aggression: Using Deep Brain Stimulation to Treat Resistant Aggression

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
6 (estimated)
Sponsor
University Hospital, Rouen · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

Physical aggression can be defined as the use of force with the intention of causing physical injury, psychological damage or death. Pathological aggression may be associated with various psychiatric disorders. This symptom can often be improved by prescribing medication, implementing psychoeducational strategies or even electroconvulsive therapy. However, some patients exhibit such severe pathological aggression that they must be institutionalised because they pose a danger to themselves or others. These patients are then hospitalised in a unit for difficult patients (UMD) for enhanced therapeutic care. Despite this maximum level of care, the pathological aggression of a minority of patients persists, leading to a therapeutic impasse, confining the patient to the UMD for many years with social isolation, a collapsed quality of life, and major repercussions for the family. The aim of this project is to use deep brain stimulation, a controlled, reversible, adaptable and low-morbidity neurosurgical method, in six patients with pathological aggression suffering from either schizophrenia (n=3) or autism spectrum disorders (n=3). We hypothesise that the effects of deep brain stimulation (DBS) of the Sano triangle will significantly control the pathological aggression of these six patients. This is a pilot study with randomised, crossover, double-blind evaluation. It will also provide answers regarding the safety of using SCP for this indication.

Conditions

Interventions

TypeNameDescription
DEVICEneurostimulatorimplantation of a neurostimulator and stimulation of the triangle of Sano by alternating ON and OFF phases

Timeline

Start date
2026-01-13
Primary completion
2028-10-08
Completion
2028-12-08
First posted
2026-01-02
Last updated
2026-01-02

Source: ClinicalTrials.gov record NCT07315685. Inclusion in this directory is not an endorsement.